MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$13,183,259
Prepaid expenses and
other current assets
$247,927
Prepaid clinical trial
costs
$81,742
Total current assets
$13,512,928
Non-current prepaid
clinical trial costs
$819,721
Total assets
$14,332,649
Total liabilities and
stockholders equity
$14,332,649
Total liabilities
$9,782,914
Total stockholders'
equity
$4,549,735
Accumulated deficit
-$180,770,273
Total current
liabilities
$9,738,408
Warrant liabilities
$44,506
Additional paid-in capital
$185,310,390
Common stock, par value
of 0.0001...
$9,618
Accounts payable
$5,431,806
Accrued clinical
expenses
$2,891,175
Accrued compensation
$784,956
Other accrued
liabilities
$630,471
Back
Back
Balance Sheet
source: myfinsight.com
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW)